Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism DPP-1 inhibitors(Cathepsin C inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Preclinical | Switzerland | 02 Sep 2025 | |
| Inflammation | Preclinical | Switzerland | 02 Sep 2025 | |
| Pulmonary Disease, Chronic Obstructive | Preclinical | Switzerland | 02 Sep 2025 |





